...Good morning. I'm Jeremy Levin, Chairman of the Board of Directors and Chief Executive Officer of Ovid Therapeutics. And it's my pleasure to welcome you to the company's 2024 Annual Meeting of Stockholders. It's now after 10:00 AM. And I will call this meeting to order and proceed with introduction and formal business of the Annual Meeting. I'd like to start off by thanking everyone for joining us today. Please let me introduce the members of our senior management team present today: Thomas Perone, General Counsel and Corporate Secretary; Jeff Rona, Chief Business and Financial Officer; Jason Tardio, Chief Commercial Officer; Meg Alexander, Chief Strategy and Corporate Affairs Officer. We're also pleased to introduce the other members of our Board of Directors who've joined us today: Dr. Karen Bernstein and Bart Friedman. I'd like to introduce Joseph Epstein, Jeff Knight, and Perron Armaly of KPMG LLP, our independent registered public accounting firm, each of whom are available to respond...